Skip to main content
Review article

The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment

Yanping GaoDepartment of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, ChinaBing FengDepartment of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, ChinaSiqi HanDepartment of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, ChinaKai ZhangDepartment of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, ChinaJing ChenDepartment of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, ChinaChen LiDepartment of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, ChinaRui WangDepartment of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, ChinaLongbang ChenDepartment of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China
2016en
ABI

Abstract

Cancer remains one of the most threatening causes of human health impairment, and the mechanisms underlying tumorigenesis have not been completely characterized. MicroRNAs (miRNAs) are a group of endogenous, small (18∼25 nucleotides) non-coding RNAs which negatively regulate gene expressions by directly binding to the 3'-untranslated regions (3'-UTRs) of the target messenger RNAs (mRNAs). Increasing evidence has demonstrated abnormal miRNA profiles and confirmed their involvement in tumor initiation and progression. As one important member of the miR-200 family, microRNA (miR)-141 is aberrantly expressed in many human malignant tumors, participating in various cellular processes including epithelial-mesenchymal transition (EMT), proliferation, migration, invasion, and drug resistance. In the present review, we briefly describe the mechanisms underlying miR-141-mediated tumorigenesis and the possible future of miR-141 as a potential diagnostic and prognostic parameter as well as therapeutic target in clinical applications.

Identifiers

Citations and references

Cited by 20 references